Page last updated: 2024-10-24

pre-B cell allelic exclusion

Definition

Target type: biologicalprocess

Expression of a single heavy chain allele during pre-B cell differentiation. [GOC:add, GOC:jal, ISBN:0781735149]

Pre-B cell allelic exclusion is a critical process in B cell development that ensures each B cell expresses only one functional immunoglobulin (Ig) heavy chain allele. This process is essential for maintaining the integrity of the immune system and preventing autoimmunity.

The process begins with the rearrangement of Ig heavy chain genes in pro-B cells. During this process, the variable (V), diversity (D), and joining (J) gene segments of the Ig heavy chain locus are randomly recombined, resulting in a unique Ig heavy chain protein.

If this rearrangement is successful, the pro-B cell expresses the newly generated Ig heavy chain protein on its surface, along with surrogate light chains, forming the pre-B cell receptor (pre-BCR). The pre-BCR signals through a complex signaling pathway that leads to several critical events, including:

* **Allelic exclusion:** The pre-BCR signal blocks further rearrangement of the other Ig heavy chain allele. This ensures that only one functional Ig heavy chain allele is expressed in each B cell.
* **Pre-B cell proliferation:** The pre-BCR signal triggers a wave of proliferation, allowing the B cell to expand and generate a clonal population.
* **Light chain gene rearrangement:** The pre-BCR signal promotes the initiation of Ig light chain gene rearrangement.

After the light chain genes are successfully rearranged, the B cell expresses a complete Ig molecule on its surface, forming the mature B cell receptor (BCR). The BCR can now bind to specific antigens and initiate an immune response.

Pre-B cell allelic exclusion is a tightly regulated process involving several molecular mechanisms, including:

* **Chromatin modifications:** The pre-BCR signal induces changes in chromatin structure that prevent further rearrangements of the second Ig heavy chain allele.
* **Transcription factors:** Several transcription factors are involved in regulating Ig gene expression and ensuring allelic exclusion, including Pax5, E2A, and Ikaros.
* **Signaling pathways:** The pre-BCR signal activates several signaling pathways, including the PI3K/Akt, Ras/MAPK, and NF-κB pathways, which contribute to the regulation of allelic exclusion.

Failure of allelic exclusion can lead to the production of B cells that express multiple Ig heavy chains. This can result in autoimmunity, as these cells may produce antibodies that target self-antigens. Therefore, pre-B cell allelic exclusion is essential for maintaining immune homeostasis and preventing autoimmune diseases.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Serine-protein kinase ATMA serine-protein kinase ATM that is encoded in the genome of human. [PRO:CNA]Homo sapiens (human)

Compounds (20)

CompoundDefinitionClassesRoles
pd 173074aromatic amine;
biaryl;
dimethoxybenzene;
pyridopyrimidine;
tertiary amino compound;
ureas
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist
caffeinepurine alkaloid;
trimethylxanthine
adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first sourcechromones;
morpholines;
organochlorine compound
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector
schizandrin bschizandrin B: a phytogenic antineoplastic agent with anti-inflammatory activity; isolated from Schisandra plant
thioureathiourea : The simplest member of the thiourea class, consisting of urea with the oxygen atom substituted by sulfur.

Thiourea: A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed). Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS.
one-carbon compound;
thioureas;
ureas
antioxidant;
chromophore
ku 559332-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one: specific inhibitor of the ataxia-telangiectasia mutated kinase ATM; structure in first source
cgk 733diarylmethane
nu 70262-(morpholin-4-yl)benzo(h)chromen-4-one: a radiosensitizing agent that inhibits DNA-dependent protein kinase; structure in first sourceorganic heterotricyclic compound;
organooxygen compound
nu 74418-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one: structure in first sourcedibenzothiophenes
ku-0060648dibenzothiophenes
dactolisibdactolisib : An imidazoquinoline that is 3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]quinoline substituted at position 1 by a 4-(1-cyanoisopropyl)phenyl group and at position 8 by a quinolin-3-yl group. A dual PI3K/mTOR inhibitor used in cancer treatment.

dactolisib: antineoplastic agent that inhibits both phosphatidylinositol 3-kinase and mTOR
imidazoquinoline;
nitrile;
quinolines;
ring assembly;
ureas
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
ku 60019
cp 466722quinazolines
(3R)-4-[2-(1H-indol-4-yl)-6-(1-methylsulfonylcyclopropyl)-4-pyrimidinyl]-3-methylmorpholineindoles
ve 8213-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide: an antineoplastic agent; structure in first sourcearomatic amide
torin 2torin 2 : A member of the class of pyridoquinolines that is benzo[h][1,6]naphthyridin-2-one carrying additional 3-(trifluoromethyl)phenyl and 6-aminopyridin-3-yl substituents at positions 1 and 9 respectively. It is a potent inhibitor of mTOR and exhibits anti-cancer properties.aminopyridine;
organofluorine compound;
primary amino compound;
pyridoquinoline
antineoplastic agent;
mTOR inhibitor
byl719proline derivative
cc-1151-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino(2,3-b)pyrazin-2(1H)-one: an mTOR kinase inhibitor; structure in first source
vx-970berzosertib: an ATR kinase inhibitorsulfonamide
etp-46464ETP-46464: inhibits ATM and Rad3-related kinase; structure in first source